Response and Side Effects from Rheumatoid Arthritis Therapy at Dr. Soetomo General Hospital Surabaya 2017
Introduction: Rheumatoid arthritis (RA) is an autoimmune disease which mainly attacks synovial membrane and causes systemic manifestation. During treatment, controlling disease activity is needed to prevent further complication. On the other hand, medications used in the treatment of RA may bring various side effects. It is important to evaluate side effects from the given therapy.
Methods: This study aimed to evaluate response and side effects of therapy in RA patients. The samples were collected from 59 RA patients at Rheumatology Division of Outpatient Clinic in Department of Internal Medicine Dr. Soetomo General Hospital Surabaya in 2017. This study method was descriptive observational with cross sectional design using medical records.
Results: Pain was reduced in 83.1% patients, Erythrocyte Sedimentation Rate (ESR) increased in 61.4% patients, and C-Reactive Protein (CRP) decreased in 50% patients. Based on the statistic analysis, ESR decreased significantly (p = 0.012) while CRP decreased not significantly (p = 0.415). The side effects were observed from clinical and laboratory data. Based on clinical symptoms, there were alopecia in 1.7% patient, dyspepsia in 78% patients, infection in 27.1% patients, and other symptoms including itchy skin, neuropathy, hyperuricemia, hyperkalemia and Acute Kidney Injury (AKI). Meanwhile, abnormalities in laboratory data include increased aspartate transaminase (AST) in 3.8% patients, increased alanine transaminase (ALT) in 26.1% patients, increased Blood Urea Nitrogen (BUN) in 7.9% patients, increased creatinine serum in 7.9% patients, decreased hemoglobin in 15.5% patients, and decreased leukocytes in 3.4% patients.
Conclusion: Most patients had a good therapeutic response based on decreased pain, while ESR had a significant decrease and CRP did not have significant decrease. Side effects discovered in patients were various
Indonesian Rheumatology Association. Diagnosis & Penatalaksanaan Artritis Reumatoid – Perhimpunan Reumatologi Indonesia, https://reumatologi.or.id/rekomendasi-perhimpunan-reumatologi-indonesia-reumatoid-artritis-2014/ (2014).
Li R, Sun J, Ren LM, Wang HY, Liu WH, Zhang XW. Epidemiology of Eight Common Rheumatic Diseases in China: A Large-Scale Cross-Sectional Survey in Beijing. Rheumatology 2012; 51: 721–729.
Cojocaru M, Cojocaru I, Silosi I, Vraibie CD, Tanasescu R. Extra-articular Manifestations of Rheumatoid Arthritis. Nauchno-Prakticheskaya Revmatol 2010; 5: 286–291.
Kumar P, Banik S. Pharmacotherapy Options in Rheumatoid Arthritis. Clin Med Insights Arthritis Musculoskelet Disord 2013; 6: 35–43.
Darmawan J, Muirden K., Valkenburg H., Wigley R.. The Epidemiology of Rheumatoid Arthritis in Indonesia. Rheumatology 1993; 32: 537–540.
Kvien T, Uhlig T, ØDEGÅRD S. Epidemiological Aspects of Rheumatoid Arthritis. Ann N Y Acad Sci 2006; 1069: 212–222.
Jeong H, Baek SY, Kim SW, Eun YH, Kim IY, Kim H. Comorbidities of Rheumatoid Arthritis: Results from the Korean National Health and Nutrition Examination Survey. PLoS One 2017; 12: 1–15.
Elsaman A, Radwan A, Abou Dahab M, Sherif AM, Al-Fadl AM. AB0291 Epidemiology and Comorbidity of Rheumatoid Arthritis in Upper Egypt, a Hospital Based Study. Ann Rheum Dis; 76. Epub ahead of print 2017. DOI: 10.1136/annrheumdis-2017-eular.1440.
Horiuchi AC, Pereira LHC, Kahlow BS, Silva MB, Skale TL. Rheumatoid arthritis in elderly and young patients. Rev Bras Reumatol (English Ed 2017; 57: 491–494.
Innala L, Berglin E, Möller B, Ljung L, Smedby T, Sodergren A. Age at Onset Determines Severity and Choice of Treatment in Early Rheumatoid Arthritis: A prospective study. Arthritis Res Ther 2014; 16: 1–9.
Rosner J, Mosheimer-Feistritzer B, Gruber J, Herold M, Mur E, Weiss G. FRI0083 Prevalence of Anemia in a Cohort of Rheumatoid Arthritis Patients- An Interim Analysis. Ann Rheum Dis; 74. Epub ahead of print 2015. DOI: 10.1136/annrheumdis-2015-eular.2745.
El Dessouky TM, El Khair EA, Koura RA, El Sharkawy S. Assessment of The Audiovestibular System in Patients with Rheumatoid Arthritis. Egypt J Otolaryngol 2017; 33: 650–655.
Zhang T, Pope J. Cervical Spine Involvement in Rheumatoid Arthritis Over Time: Results from a Meta-Analysis. Arthritis Res Ther 2015; 17: 1–9.
Ghosh S, Bandyopadhyay D, Biswas S, Darung I. Mucocutaneous Manifestations in Patients with Rheumatoid Arthritis: A Cross-Sectional Study from Eastern India. Indian J Dermatol 2017; 62: 411–417.
Karpova Y, Belov B, Egorova O. SAT0555 Erythema Nodosum in Rheumatology Clinic: A Study of 130 Cases. Ann Rheum Dis; 74. Epub ahead of print 2015. DOI: 10.1136/annrheumdis-2015-eular.2352.
Abbasi M, Yazdi Z, Rezaie N. Sleep Disturbances in Patients with Rheumatoid Arthritis. Niger J Med 2013; 22: 181–186.
Westhovens R, Van Der Elst K, Matthys A, Tran M, Gilloteau I. Sleep Problems in Patients with Rheumatoid Arthritis. J Rheumatol 2014; 41: 31–40.
Sulaiman W, Toib A, Chandrashekhar G, Arshad A. The trends of DMARDS Prescribed in Rheumatoid Arthritis Patients in Malaysia. Oman Med J 2009; 24: 260–263.
Kirwan J, The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis. N Engl J Med 1995; 333: 142–6.
Geborek P, Månsson B, Wollheim F, Moritz U. Intraarticular Corticosteroid Injection into Rheumatoid Arthritis Knees Improves Extensor Muscles Strength. Rheumatol Int 1990; 9: 265–270.
Meinicke J, Danneskiold-samsøe B. Diclofenac Sodium (Voltaren®) and Ibuprofen in Rheumatoid Arthritis A Randomized Double-blind Study. Scand J Rheumatol 1980; 9: 1–8.
Scharbatke EC, Behrens F, Schmalzing M, Khoem M, Greger G, Gnann H. Association of Improvement in Pain With Therapeutic Response as Determined by Individual Improvement Criteria in Patients With Rheumatoid Arthritis. Arthritis Care Res 2016; 68: 1607–1615.
Siemons L, Ten Klooster PM, Vonkeman HE, van Riel P, Glas C van de M. How Age and Sex Affect The Erythrocyte Sedimentation Rate and C-reactive Protein in Early Rheumatoid Arthritis. BMC Musculoskelet Disord 2014; 15: 1–7.
Murav’ev I V, Gridneva G, Karateev D, Luchikhina EL, Omonin IuL, Aleksandrova EN. Evaluation of Methotrexate Effect on The Acute-Phase Response in Rheumatoid Arthritis after 12-week Treatment. Klin Med (Mosk) 2014; 92: 59–63.
Emery P, Breedveld FC, Lemmel EM, Kaltwasser JP, Dawes PT, Gomor B. A Comparison of The Efficacy and Safety of Leflunomide and Methotrexate for The Treatment of Rheumatoid Arthritis. Rheumatology 2000; 39: 655–665.
Jones PBB, White DHN. Reappraisal of The Clinical Use of Leflunomide in Rheumatoid Arthritis and Psoriatic Arthritis. Open Access Rheumatol Res Rev 2010; 2: 53–71.
Germano V, Cattaruzza MS, Osborn J, Tarantino A, Di Rosa R, Salemi S. Infection Risk in Rheumatoid Arthritis and Spondyloarthropathy Patients under Treatment with DMARDs, Corticosteroids and TNF-α antagonists. J Transl Med 2014; 12: 1–10.
Bharadwaj A, Haroon N. Peripheral Neuropathy in Patients on Leflunomide. Rheumatology 2004; 43: 934.
Hörl WH. Nonsteroidal Anti-Inflammatory Drugs and The Kidney. Pharmaceuticals 2010; 3: 2291–2321.
Razak SA, Islahudin F, Shamsuddin AF, Islahudin F, Shahri NS. A Study on Leflunomide-Induced Liver Injury in Rheumatoid Arthritis Patients. Res J Pharm Technol 2013; 6: 556–561.
Sriuttha P, Sirichanchuen B, Permsuwan U. Hepatotoxicity of Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review of Randomized Controlled Trials. Int J Hepatol; 2018. Epub ahead of print 2018. DOI: 10.1155/2018/5253623.
Chiu HY, Huang HL, Li CH, Chen HA, Yeh L, Chiu SH. Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications - A national population-based cohort study. PLoS One 2015; 10: 1–13.
Karstila K, Rantalaiho V, Mustonen J, Mottonen TT, Hannonen PJ, Leirisalo-Repo M. Renal Safety of Initial Combination versus Single DMARD Therapy in Patients with Early Rheumatoid Arthritis: an 11-year Experience from The FIN-RACo Trial. Clin Exp Rheumatol 2019; 28: 73–8.
Gutierrez-Ureña S, Molina J, García C, Cuellar ML, Espinoza LR. Pancytopenia Secondary to Methotrexate Therapy in Rheumatoid Arthritis. Arthritis and Rheumatism. Arthritis Rheum 1996; 39: 272–6.
Mori S, Hidaka M, Kawakita T, Hidaka T, Tsuda H, Yoshitama T. Factors associated with myelosuppression related to low-dose methotrexate therapy for inflammatory rheumatic diseases. PLoS One 2016; 11: 1–13.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).